Allergy Therapeutics PLC (AGYTF)
0.02
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Allergy Therapeutics Debt to Equity Ratio: 0.0598 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.0598 |
June 30, 2023 | 13.11 |
December 31, 2022 | 0.052 |
June 30, 2022 | 0.0648 |
December 31, 2021 | 0.0524 |
June 30, 2021 | 0.0703 |
December 31, 2020 | 0.0651 |
June 30, 2020 | 0.0858 |
December 31, 2019 | 0.0386 |
June 30, 2019 | 0.0649 |
December 31, 2018 | 0.062 |
June 30, 2018 | 0.1328 |
December 31, 2017 | 0.0889 |
June 30, 2017 | 0.111 |
December 31, 2016 | 0.0878 |
June 30, 2016 | 0.111 |
December 31, 2015 | 0.0351 |
June 30, 2015 | 0.0489 |
December 31, 2014 | 0.0023 |
June 30, 2014 | 0.0033 |
December 31, 2013 | 0.0045 |
Date | Value |
---|---|
June 30, 2013 | 0.0196 |
December 31, 2012 | 0.0106 |
June 30, 2012 | 0.1044 |
December 31, 2011 | 0.8959 |
June 30, 2011 | 5.779 |
December 31, 2010 | 1.038 |
June 30, 2010 | 3.012 |
December 31, 2009 | 1.462 |
June 30, 2009 | -1.334 |
December 31, 2008 | -1.716 |
June 30, 2008 | -2.288 |
December 31, 2007 | 7.104 |
June 30, 2007 | 0.2514 |
December 31, 2006 | 0.00 |
June 30, 2006 | 0.00 |
December 31, 2005 | 0.00 |
June 30, 2005 | 0.0227 |
December 31, 2004 | 0.00 |
June 30, 2004 | 0.1638 |
December 31, 2003 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0386
Minimum
Dec 2019
13.11
Maximum
Jun 2023
1.366
Average
0.0648
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 88.00M |
Total Liabilities (Quarterly) | 54.29M |
Shareholders Equity (Quarterly) | 33.71M |
Current Ratio | 1.399 |
Net Debt Paydown Yield | 0.67% |